Alora Pharmaceuticals, Llc (United States) has no DMF, CEP or site registration linked in our records. 40 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Alora Pharmaceuticals, Llc: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/alora-pharmaceuticals-llc

Overview

Alora Pharmaceuticals, Llc is a pharmaceutical company headquartered in Alpharetta, United States.

FDA compliance signals

40 FDA enforcement records linked to this company.

  • warning_letter2025-09-09

    FDA Warning Letter (drug product)

  • 4832024-12-18

    Late submission of annual safety reports

  • 4832024-12-18

    Late submission of quarterly safety reports

  • 4832024-12-18

    Timely submission

  • 4832023-11-08

    Procedures not in writing, fully followed

  • 4832023-11-08

    Returned drug procedures in writing and followed

  • 4832023-11-08

    Investigations of discrepancies, failures

  • 4832023-11-08

    Control procedures to monitor and validate performance

  • 4832023-02-10

    Investigations of discrepancies, failures

  • 4832023-02-10

    Approve or reject procedures or specs

  • 4832023-02-10

    Procedures to be written and followed

  • 4832023-02-10

    Scientifically sound laboratory controls

  • 4832021-09-17

    Procedures to be written and followed

  • 4832021-09-17

    Approve or reject components, products

  • 4832021-09-17

    Investigations of discrepancies, failures

  • 4832021-09-17

    SOPs not followed / documented

  • 4832021-09-17

    Training , Education , Experience overall

  • warning_letter2020-08-14

    FDA Warning Letter (drug product)

  • 4832019-03-29

    Timely submission

  • 4832019-03-29

    Late submission of annual safety reports

  • 4832017-03-08

    Timely submission

  • 4832017-03-08

    Failure to develop written procedures

  • 4832017-03-08

    Interval

  • 4832015-10-28

    Procedures not in writing, fully followed

  • 4832015-10-28

    Storage under appropriate conditions

  • 4832013-10-31

    Items to cover on annual reviews

  • 4832013-10-31

    Test methods

  • 4832013-10-31

    Written record of investigation incomplete

  • 4832013-10-31

    Control procedures to monitor and validate performance

  • 4832013-10-31

    Responsible firm officials notified in writing

  • 4832013-10-31

    Contract drug products--lack of responsibility

  • 4832013-10-31

    Complaint Investigation/Follow-Up Findings

  • 4832013-10-31

    GMP Training Frequency

  • 4832012-03-22

    Returned drug procedures in writing and followed

  • 4832012-03-22

    Procedures not in writing, fully followed

  • 4832012-03-22

    Recall facilitation

  • 4832010-04-02

    Quality control unit review of records

  • 4832010-04-02

    Procedures not in writing, fully followed

  • 4832010-04-02

    SOPs not followed / documented

  • 4832010-04-02

    Written complaint record must include

For suppliers

Is this Alora Pharmaceuticals, Llc?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.